আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu 15.000 anti-xa iu
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu - 15.000 anti-xa iu
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
fragmin stungulyf, lausn í áfylltri sprautu með nálarvörn 15.000 and-xa a.e.
pfizer aps - dalteparinum natricum inn - stungulyf, lausn í áfylltri sprautu með nálarvörn - 15.000 and-xa a.e.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
influvactetra (influvac tetra) stungulyf, dreifa í áfylltri sprautu 15/15/15/15 míkróg/skammt
viatris aps - b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð); a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2)- líkur stofn (a/darwin/9/2021, san-010); b/austria/1359417/2021-like strain (b/austria/1359417/2021, bvr-26) - stungulyf, dreifa í áfylltri sprautu - 15/15/15/15 míkróg/skammt
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
taptiqom sine (taptiqom) augndropar, lausn 15 microg/ml + 5 mg/ml
santen oy* - tafluprostum inn; timololum maleat - augndropar, lausn - 15 microg/ml + 5 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
bleomycin baxter stungulyfs-/innrennslisstofn, lausn 15.000 a.e.
baxter medical ab* - bleomycinum súlfat - stungulyfs-/innrennslisstofn, lausn - 15.000 a.e.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
taflotan augndropar, lausn í stakskammtaíláti 15 míkróg/ml
santen oy* - tafluprostum inn - augndropar, lausn í stakskammtaíláti - 15 míkróg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
taflotan sine (taflotan) augndropar, lausn 15 míkróg/ml
santen oy* - tafluprostum inn - augndropar, lausn - 15 míkróg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
taptiqom augndropar, lausn í stakskammtaíláti 15 microg/ml + 5 mg/ml
santen oy - tafluprostum inn; timololum maleat - augndropar, lausn í stakskammtaíláti - 15 microg/ml + 5 mg/ml
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
vaxigriptetra stungulyf, dreifa í áfylltri sprautu 15 míkróg
sanofi pasteur* - a/victoria/2570/2019 (h1n1)pdm09 - líkur stofn (a/victoria/2570/2019, ivr-215); a/darwin/9/2021 (h3n2) - líkur stofn (a/darwin/9/2021, ivr-228); b/austria/1359417/2021 - líkur stofn (b/michigan/01/2021, villigerð); b/phuket/3073/2013-líkur stofn (b/phuket/3073/2013, villigerð) - stungulyf, dreifa í áfylltri sprautu - 15 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
norditropin flexpro stungulyf, lausn 15/1,5 mg/ml
novo nordisk a/s* - somatropinum inn - stungulyf, lausn - 15/1,5 mg/ml